Core Viewpoint - The company, Chaoyue Eye Care (02219), has announced a share buyback program, indicating confidence in its business outlook and potential to create value for shareholders [1] Summary by Sections Share Buyback Authorization - The board of directors has resolved to repurchase up to HKD 50 million worth of company shares starting from November 17, 2025, based on the authorization approved at the annual general meeting on June 6, 2025 [1] - The board may increase the maximum purchase amount under the buyback authorization depending on market conditions, with timely announcements to be made as necessary [1] Financial Position - The board believes that the company's existing financial resources are sufficient to implement the share buyback while maintaining a robust financial position [1]
朝聚眼科拟购回最多价值5000万港元的公司股份